Who
Francesco De Rubertis
Director
Company insider
Files Form 4 as: Director, Centessa Pharmaceuticals; Director and 10% owner, Minerva Neurosciences; Director, Versartis.
In numbers
- Trades disclosed
- 44
- Buys
- 8
- Sells
- 1
- Bought
- $25.1M
- Sold
- $10.0M
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 20 Mar 2014
- Last trade
- 24 Jun 2026
- Last filed
- 24 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Jun 2026filed 24 Jun 2026 | Centessa PharmaceuticalsBiotechnology | SEC FORM 4 Code D | —4,398,519 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa PharmaceuticalsBiotechnology | SEC FORM 4 Code D | —55,677 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa PharmaceuticalsBiotechnology | SEC FORM 4 Code D | —3,936,970 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa PharmaceuticalsBiotechnology | SEC FORM 4 Code D | —93,526 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa PharmaceuticalsBiotechnology | SEC FORM 4 Code D | —11,197,303 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa PharmaceuticalsBiotechnology | SEC FORM 4 Code D | —281,162 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticals | SEC FORM 4 Code D | —4,398,519 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticals | SEC FORM 4 Code D | —55,677 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticals | SEC FORM 4 Code D | —3,936,970 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticals | SEC FORM 4 Code D | —93,526 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticals | SEC FORM 4 Code D | —11,197,303 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticals | SEC FORM 4 Code D | —281,162 | filing |
| 21 Mar 2022filed 23 Mar 2022 | Centessa Pharmaceuticals | SEC FORM 4 Code J | —1,794,211 at $0.00 | filing |
| 21 Mar 2022filed 23 Mar 2022 | Centessa Pharmaceuticals | SEC FORM 4 Code J | —45,054 at $0.00 | filing |
| 2 Dec 2021filed 6 Dec 2021 | Centessa Pharmaceuticals | SEC FORM 4 Bought | $430K33,530 at $12.82 | filing |
| 2 Dec 2021filed 6 Dec 2021 | Centessa Pharmaceuticals | SEC FORM 4 Bought | $10K796 at $12.82 | filing |
| 1 Dec 2021filed 2 Dec 2021 | Centessa Pharmaceuticals | SEC FORM 4 Bought | $743K58,905 at $12.62 | filing |
| 1 Dec 2021filed 2 Dec 2021 | Centessa Pharmaceuticals | SEC FORM 4 Bought | $18K1,399 at $12.62 | filing |
| 30 Nov 2021filed 2 Dec 2021 | Centessa Pharmaceuticals | SEC FORM 4 Bought | $418K35,992 at $11.62 | filing |
| 30 Nov 2021filed 2 Dec 2021 | Centessa Pharmaceuticals | SEC FORM 4 Bought | $9,935855 at $11.62 | filing |
News
No headline names them, or the companies they trade most, lately.